Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy
Pharmaceuticals · 01.03.2024 · 17 (3) · 329
DOI: 10.3390/ph17030329 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 01.03.2024. Verfasst von Priya Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Saurashtra University, Rajkot 360005, Gujarat, India. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research received no external funding, and The APC was funded by Chiang Mai University..
Abstract (Originalsprache)
In recent years, due to their distinctive and adaptable therapeutic effects, many natural bioactive compounds have been commonly used to treat diseases. Their limited solubility, low bioavailability, inadequate gastrointestinal tract stability, high metabolic rate, and shorter duration of action limited their pharmaceutical applications. However, those can be improved using nanotechnology to create various drug delivery systems, including lipid-based nanoparticles, to adjust the compounds’ physicochemical properties and pharmacokinetic profile. Because of the enormous technical advancements made in the fundamental sciences and the physical and chemical manipulation of individual atoms and molecules, the subject of nanotechnology has experienced revolutionary growth. By fabricating certain functionalized particles, nanotechnology opens an innovative horizon in research and development for overcoming restrictions, including traditional medication administration systems. Nanotechnology-driven bioactive compounds are certain to have a high impact and clinical value for current and future uses. Lipid-based nanotechnologies were shown to deliver a range of naturally occurring bioactive compounds with decent entrapment potential and stability, a successfully controlled release, increased bioavailability, and intriguing therapeutic activity. This review outlines bioactive compounds such as paclitaxel, curcumin, rhodomyrtone, quercetin, kaempferol, resveratrol, epigallocatechin-3-gallate, silymarin, and oridonin, fortified within either a natural or synthetic lipid-based drug delivery system based on nanotechnology and their evaluation and clinical considerations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Saurashtra University, Rajkot 360005, Gujarat, India.
- School of Pharmaceutical Sciences, Atmiya University, Rajkot 360005, Gujarat, India.
- Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
- Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva 384012, Gujarat, India.
ORCID-Profile: Priya Patel, Kevinkumar Garala, Sudarshan Singh, Bhupendra G Prajapati, Chuda Chittasupho
Förderung
- This research received no external funding, and The APC was funded by Chiang Mai University.
Zitieren
APA
Patel, P., Garala, K., Singh, S., Prajapati, B. G., & Chittasupho, C. (2024). Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy. Pharmaceuticals, 17(3), 329. https://doi.org/10.3390/ph17030329
Vancouver
Patel P, Garala K, Singh S, Prajapati BG, Chittasupho C. Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy. Pharmaceuticals. 2024;17(3):329. doi:10.3390/ph17030329
BibTeX
@article{Patel2024,
author = {Patel, Priya and Garala, Kevinkumar and Singh, Sudarshan and Prajapati, Bhupendra G and Chittasupho, Chuda},
title = {Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {3},
pages = {329},
doi = {10.3390/ph17030329}
}
EUVIMED